Next Article in Journal
How Accurate Are Veterinary Clinicians Employing Flexicult Vet for Identification and Antimicrobial Susceptibility Testing of Urinary Bacteria?
Next Article in Special Issue
Exposure to Bacteriophages T4 and M13 Increases Integrin Gene Expression and Impairs Migration of Human PC-3 Prostate Cancer Cells
Previous Article in Journal
Enhancement of Antibiofilm Activity of Ciprofloxacin against Staphylococcus aureus by Administration of Antimicrobial Peptides
Previous Article in Special Issue
Anti-Cancer and Anti-Inflammatory Potential of the Green Synthesized Silver Nanoparticles of the Red Sea Sponge Phyllospongia lamellosa Supported by Metabolomics Analysis and Docking Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Paralemnolins X and Y, New Antimicrobial Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide

1
Department of Natural Compounds Chemistry, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt
2
Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt
3
National Institute of Oceanography & Fisheries, NIOF, Cairo 11516, Egypt
4
Chemistry of Natural& Microbial Products Department, National Research Centre, Dokki, Giza 12622, Egypt
5
Graduate School of Integrated Sciences for Life, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima 739-8521, Japan
6
Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan
7
Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA
8
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany
*
Authors to whom correspondence should be addressed.
Antibiotics 2021, 10(10), 1158; https://doi.org/10.3390/antibiotics10101158
Submission received: 6 September 2021 / Revised: 21 September 2021 / Accepted: 22 September 2021 / Published: 24 September 2021

Abstract

:
The organic extracts of the Red Sea soft coral Paralemnalia thyrsoides has led to the identification of two neolemnane-type sesquiterpenoids: paralemnolins X and Y (1, 2). In addition to these newly characterized compounds, ten known metabolites (312) were isolated. Previously reported compounds were elucidated by literature comparison of spectroscopic data (1D and 2D NMR as well as MS data). In vitro antimicrobial activity was investigated for compounds (112) against Staphylococcus aureus, Escherichia coli, Candida albicans and Aspergillus niger. Compound 5 showed antimicrobial activity against all assayed microorganisms.

1. Introduction

While natural product research includes plant, marine animal and microbe sources, more recently, marine flora and fauna have afforded an exciting number of potential therapeutic agents that are currently in preclinical and clinical evaluation due to promising biological activities with in vivo and in vitro assays [1,2,3,4,5,6,7]. Such drug leads have also significantly contributed to our understanding of cellular biochemical processes. Typical marine skeletons combined with robust biological activities have attracted the attention of pharmacists, chemists and biologists [8,9,10,11].
With the high endemic biota observed in the Red Sea, this marine region serves as an epicenter for marine biodiversity. Indeed, the Red Sea is home to over 40% of the 180 soft coral species that have been discovered worldwide [12]. Soft corals of the genus Lemnalia and Paralemnalia, in particular, have been discovered to be a significant source of bioactive chemicals such as sesquiterpenoids of the nardosinane, neolemnane and africanane types [13,14,15,16]. Norsesquiterpenes have been found to be abundant in Paralemnalia thyrsoides (Alcyonaceae) soft coral [14,16,17,18,19,20,21]. Previous chemical studies of P. thyrsoides resulted in the isolation of sesquiterpenoids known as paralemnolins A—W [18,19,21,22,23].
Here we report on two neolemnane-type sesquiterpenoids isolated from the Formosan soft coral P. thyrsoides.

2. Results and Discussion

Chromatographic fractionation and purification of the EtOAc extract of P. thyrsoides afforded two new sesquiterpenes known as paralemnolin X (1) and paralemnolin Y (2), as well as 10 previously reported compounds, paralemnolin D (3) [18], paralemnolin E (4) [18], paralemnolin J (5) [21], paralemnolin P (6) [21], 2-deoxy-12-oxolemnacarnol (7) [14], paralemnolide A (8) [24], parathyrsoidin G (9) [25], 6α-acetyl-1(10)-α-13-nornardosin-7-one (10) [15], 6α-acetyl-7α-acetate-1(10)-α-13-nornardosine (11) [15], and clavukoellian F (12) [26] (Figure 1). All isolated secondary metabolites were elucidated by 1D and 2D-NMR as well as mass spectroscopy (Figures S1–S48).
Compound 1 was obtained in the form of a colourless oil exhibiting a positive optical rotation in methanol [ α ] D 25 + 67.5 (C 0.01, MeOH). CI-MS analysis showed a molecular ion peak at 336.1940, indicating a molecular formula of C19H28O5 (calculated 336.1939 for C19H28O5) and thus indicating six degrees of unsaturation. The 13C and 1H NMR spectra revealed the presence of two acetyl groups (δH 2.08 (3H, s), 2.00 (3H, s); δC169.9 (2C=O), 21.0 (2CH3)) and one double bond (δC 127.1 (CH), 143.7 (C)).The 13C NMR (Table 1) and DEPT spectra revealed 19 carbon signals, which were classified as 5 quaternary carbons (comprising two acetate keto groups at δC 169.9), 5 methines (including three oxygenated methines at δC 65.3, 72.5, 73.8 and one olefinic methines at δC 127.1), 4 methylenes, and 5 methyles (including two methyl groups of acetyl groups) in the 13C NMR spectrum, indicating the presence of two acetyl groups. Furthermore, one trisubstituted double bond at 127.1 (CH) and 143.7 (C) was assigned from the 13C NMR, DEPT and HMQC spectra. The suggested structure, a neolemnanoid skeleton, corresponded to a bicyclic structure with a condensed eight- and six-membered ring system, as previously isolated from P. thyrsoides [18]. The skeleton was established by extensive 2D NMR analysis (HMQC, HMBC and 1H–1H COSY). The 1H–1H COSY spectrum was used to reveal proton sequences and the connectivity of H-4/H-5, H-5/H2-6, H2-6/H2-7, H-9/H2-10, and H2-10/H2-11 (Figure 2). Two oxygen-bearing carbons at δC 55.4 (C) and 65.3 (CH), the latter coinciding with a proton at δH 2.96 (s) in the HMQC spectrum, confirmed a trisubstituted epoxide (Figure 2). Comparison of the NMR spectral data of compounds paralemnolin D, E, G and H revealed that the C-2–C-3 double bond was oxidized to bean epoxide group in compound 1 [18]. The epoxide site was established via H3-14 correlation to carbon signals at δC 65.3 (C-2), 55.4 (C-3), and 72.5 (C-4) in HMBC spectrum. Spectroscopic data was similar to paralemnolin F [18], except the up-field shift of C-2 at δC65.3/71.8 as well as the down-field shift of H-2 at δH 2.96 (Table 1). NMR spectral data comparison of compound 1 with paralemnolin F disclosed that both compounds had similar structures. In Table 1, the NOESY spectrum was recorded, and H3-13 was found to show NOE interactions with H3-14, H3-15 and one proton (δH 1.42, m) of H2-11; additionally, H3-14 was found to show NOE interactions with H-4 and H-5, identifying these protons as β-oriented. Furthermore, H-2 (δH 2.96, s) exhibited NOE interactions with H-12, suggesting the α-orientation of H-2 (Figure 3). The structure of 1 was determined as paralemnolin X.
Compound 2 (a colourless oil) displayed a positive optical rotation in methanol [ α ] D 25 + 25.6 (C 0.01, MeOH). CI-MS analysis showed a molecular ion peak at 336.1934, indicating a molecular formula of C19H28O5 (calculated 336.1933, for C19H28O5) and thus indicating six degrees of unsaturation. The existence of two acetyl groups (δH 2.11 (3H, s), 2.02 (3H, s); δC 169.9, 169.7 (2C=O), 20.9, 20.7 (2CH3)) and one double bond (δC 124.2 (CH), 142.1 (C)) were revealed by the 13C and 1H NMR spectra. The 13C NMR spectrum displayed 19 carbon signals, which were classified as 5 quaternary carbons (comprising two acetate keto groups at δC169.7, 169.9), 5 methines (including three oxygenated methines at δC 65.2, 75.5, 73.6 and one olefinicmethine at δC 124.2), 4 methylenes, and 5 methyles (including two methyl groups of acetyl groups) in the 13C-NMR spectrum, indicating the presence of two acetyl groups. Furthermore, one trisubstituted double bond at 124.2 (CH) and 142.1 (C) was assigned from the 13C-NMR, DEPT and HMQC spectra. These structural elements recommended that the neolemnanoid skeleton confers a bicyclic structure with a condensed 6/8-membered ring system, as previously isolated from P. thyrsoides [18]. The skeleton of 2 was established by extensive 2D NMR analysis (1H–1H COSY, HMQC, and HMBC). To establish the proton sequences, the 1H–1H COSY spectrum was used to reveal the connectivity of H-4/H-5, H-5/H2-6, H2-6/H2-7, H-9/H2-10, and H2-10/H2-11 (Figure 2). A trisubstituted epoxide was established from two oxygen-bearing carbons at δC 58.3 (C) and 65.2 (CH). The latter correlated with a proton at δH 2.89 (s) in the HMQC spectrum. Spectroscopic data was similar to 1, except for the down-field shift of C-3 at δC 58.3/55.4 and the up-field shift of C-14 at δC 13.9/19.5 (Table 1). The NMR spectra, in comparison with 1, revealed that both compounds had similar structures; in Table 1, the NOESY spectrum was recorded. H3-13 show NOE interactions with protons at δH 0.98 d (6.8, H3-15), and 2.89 (s, H-2) and one proton at δH 2.40 (m, H2-7); additionally, H-2 shows NOE interactions with protons at δH 4.77 (d, 6.0, H-4) and 5.09 (dd, 10.0, 6.0, H-5) and one proton at δH1.81 (m, H2-6), revealing a β-orientation of these protons. Furthermore, H3-14 (δH1.48, s) exhibited NOE interactions with protons at δH1.77 (m, H-12) and one proton at δH 2.10 (m, H2-6), suggesting the α-orientation H3-14 (Figure 3). The structure of compound 2 was determined as paralemnolin Y.
A microdilution assay was used to determine the MIC. Metabolite 5 was the most active compound against all test microorganisms, with weak antimicrobial activity in comparison with positive controls (treflucan and thiophenicol) while other compounds showed varying activities (see Table 2). Compound 7 exhibited no observed antimicrobial activity.

3. Materials and Methods

3.1. General Experimental Procedures

For optical rotation the JASCO P-2300 polarimeter (JASCO, Tokyo, Japan) was used; for IR spectra, the Shimazu FTIR-8400S instrument (Shimazu, Columbia, MD 21046, USA) was used. A Bruker 600 or 500 Hz NMR spectrometer was used to record 1D and 2D NMR spectra (Bruker, MA, USA). A JEOL JMS-700 equipment was used to obtain HR-MS spectra (Tokyo, Japan). TLC analysis was conducted with precoated silica gel plates (Merck, Kieselgel60 F254, 0.25 mm, Merck, Darmstadt, Germany); chromatography (CC) was conducted with silica gel 60 (Merck, 230–400 mesh, Merck, Darmstadt, Germany). HPLC was carried out with a Jasco PU-980 pump, a Jasco UV-970 intelligent UV detector at 210 nm, and a semi-preparative reversed-phase column (Cosmosil C18, column 250 × 10 mm, 5 μm, Nacalai Tesque, Kyoto, Japan).

3.2. Coral Material, Extraction and Separation

A collected Red Sea soft coral Paralemnalia thyrsoide (Hurghada in March 2017) was identified by Montaser A. Alhammady (co-author) with a voucher specimen (08RS1075) deposited in the National Institute of Oceanography and Fisheries (NIOF), Egypt.
The soft coral P. thyrsoides (2.5 kg wet weight) was sliced into small parts; this was followed by extraction with ethyl acetate (6 L × 3 times). The combined extracts afforded a dark black gum (117.5 g) under vacuum concentration. Further chromatography fractionations and purification were operated using our previously described protocol [27]. All column fractions were examined via TLC and collected as the main fractions (PT1-PT9). One fraction (PT3; 930 mg) was subjected to the silica gel column with an elution solvent system of n-hexane/CHCl3 step gradient to afford two sub-fractions (PT3-1-2) via the TLC profile. The sub-fraction PT3-1 was re-purified and rephrased. RP-18 HPLC (MeOH/H2O, 3:1) afforded compounds 1 (9.1 mg), 2 (13.4 mg), 6 (7.3 mg), 7 (5.8 mg), and 9 (10.5 mg). Fraction PT-4 (718.9 mg) was further fractionated over ODS-C18 CC using MeOH/H2O with increasing polarity as the eluent; this afforded three main subfractions (PT4-1-3). The subfraction PT4-2 (278.7 mg) was re-subjected to RP-18 HPLC (MeOH–H2O, 4:1) to give compounds 3 (7.9 mg), 4 (10.2 mg), 5 (9.3 mg), and 8 (6.7 mg). The sub-fraction PT4-3 was purified by Isolera flash column chromatography eluted with n-hexane:EtOAc (1:1) to afford compounds 10 (8.6 mg), 11 (12.6 mg), and 12 (5.8 mg).

3.3. Spectral data of Paralemnolin X, Y (1,2)

Paralemnolin X (1): yellow oil; [ α ] D 25 + 67.5 (c 0.01, CH3OH); 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HRCIMS m/z 336.1940 (calculated 336.1939 for C19H28O5).
Paralemnolin Y (2): yellow oil; [ α ] D 25 + 25.6 (c 0.01, CH3OH); 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HRCIMS m/z 336.1934 (calculated 336.1933 for C19H28O5).

3.4. Antimicrobial Activity Assay

3.4.1. Microorganisms

Staphylococcus aureus (ATCC29213) and Escherichia coli (ATCC 25922) are Gram-positive bacterium (GPB) and Gram-negative bacterium (GNB), respectively. Additionally, the fungal yeast Candida albicans (ATCC 10231) and Aspergillus niger (NRRL-599) were screened for compound anti-microbial activity by the Microbial and Natural Products Chemistry Department, National Research Centre (NRC), Egypt.
Nutrient agar medium was used for bacterial cultivation followed by suspension in nutrient broth medium at 37 °C for 24 h. The fungus culture was grown on potato dextrose agar medium at 28 °C for 4 days, and then suspended in potato dextrose broth. The turbidity of the suspension was adjusted to that of the standard 0.5 McFarland solution.

3.4.2. Minimum Inhibitory Concentration Determination

The MIC values were determined by the broth microdilution assay (NCCLS, 2008) [28] with slight modifications. Each sample was initially dissolved in DMSO, and subsequently diluted with broth media to reach the desired final concentration. Five-fold dilutions were prepared in a 96-well plate. The microbial suspensions were added into each well, then incubated at 37 °C for 24 h for bacteria and at 28 °C for 72 h for fungi. The MIC value was determined as the lowest concentration of the sample that inhibited microbial growth. The assay was carried out in nutrient broth medium for bacteria and potato dextrose broth medium for fungi. The assay was performed according to Hammer et al. (1999) [29], with slight modifications. Briefly, 1 mg of the pure compound was dissolved in 50 µL DMSO, and 10 µL was added as the initial concentration in the first column of the sterile polystyrene 96-well plates. Then, 190 µL of the tested microbial suspension adjusted to 5 × 105 CFU/mL was added. Serial dilutions were performed by the addition of 100 µL of the first column to the second one, and so on. The final volume was adjusted to 200 µL on each well by the addition of the microbial suspension to obtain final concentrations of the tested compounds ranging from 100 to 3.125 µg. Microbial growth controls were made by replacing the tested compound with the same volume of DMSO (in order to eliminate the possible antibacterial effect of the solvent). Sterility controls were prepared by using broth media alone. The plates were covered with a sterile plate sealer, carefully mixed and incubated at 37 °C for 24 h for bacteria and 28 °C for fungi. Microbial growth was indicated by the turbidity. The absence of microbial growth was interpreted as antimicrobial activity. The MIC value was taken as the lowest concentration of the test agent that caused complete inhibition (100%) of microbial growth [30].

4. Conclusions

A P. thyrsoide extract afforded two new neolemnane-type sesquiterpenoids, paralemnolins X, Y (1, 2) and ten known secondary metabolites (312). Chemical structures were elucidated based upon spectroscopic analyses. Only compound 5 exhibited antimicrobial activity against all test microorganisms, followed by compound 9. Other compounds showed varying activities against different test microorganisms.

Supplementary Materials

The following are available online https://www.mdpi.com/article/10.3390/antibiotics10101158/s1, Figures S1–S48: NMR spectra for compounds 112.

Author Contributions

Conceptualization, A.I.E., T.A.M. and M.-E.F.H.; data curation, A.I.E., T.A.M., E.M.E., I.A.S., M.A.A. and M.-E.F.H.; formal analysis, A.I.E., T.A.M., A.A.E.-B. and S.O.; investigation, A.I.E., T.A.M., A.A.E.-B. and E.M.E.; methodology, M.-E.F.H., M.A.A.; project administration, T.A.M., A.I.E., A.U. and M.-E.F.H.; resources, A.I.E., T.A.M., E.M.E., I.A.S., M.-E.F.H.; software, M.-E.F.H.; supervision, M.-E.F.H.; visualization, A.I.E., T.A.M., A.A.E.-B. and M.-E.F.H.; writing—original draft, A.I.E., T.A.M., A.A.E.-B.; writing—review & editing, A.I.E., T.A.M., E.M.E., I.A.S., S.O., P.W.P. and M.-E.F.H. All authors have read and agreed to the published version of the manuscript.

Funding

The authors would like to acknowledge the financial support from the project Secondary Metabolites from Egyptian Soft Corals: Chemical and Biological Investigation against Cancer Cells, grant number 12060120/2019-2022, financed by the National Research Centre, Giza, Egypt.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Saide, A.; Damiano, S.; Ciarcia, R.; Lauritano, C. Promising Activities of Marine Natural Products against Hematopoietic Malignancies. Biomedicines 2021, 9, 645. [Google Scholar]
  2. Lu, W.-Y.; Li, H.-J.; Li, Q.-Y.; Wu, Y.-C. Application of marine natural products in drug research. Bioorganic Med. Chem. 2021, 35, 116058. [Google Scholar]
  3. Taglialatela-Scafati, O. New hopes for drugs against COVID-19 come from the sea. Mar. Drugs 2021, 19, 104. [Google Scholar]
  4. Zuo, W.; Kwok, H.F. Development of Marine-Derived Compounds for Cancer Therapy. Mar. Drugs 2021, 19, 342. [Google Scholar]
  5. Ibrahim, M.A.A.; Abdelrahman, A.H.M.; Mohamed, T.A.; Atia, M.A.M.; Al-Hammady, M.A.M.; Abdeljawaad, K.A.A.; Elkady, E.M.; Moustafa, M.F.; Alrumaihi, F.; Allemailem, K.S. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors. Molecules 2021, 26, 2082. [Google Scholar]
  6. Ibrahim, M.A.A.; Abdelrahman, A.H.M.; Atia, M.A.M.; Mohamed, T.A.; Moustafa, M.F.; Hakami, A.R.; Khalifa, S.A.M.; Alhumaydhi, F.A.; Alrumaihi, F.; Abidi, S.H. Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Mar. Drugs 2021, 19, 391. [Google Scholar]
  7. Ibrahim, M.A.A.; Abdelrahman, A.H.M.; Hussien, T.A.; Badr, E.A.A.; Mohamed, T.A.; El-Seedi, H.R.; Pare, P.W.; Efferth, T.; Hegazy, M.-E.F. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput. Biol. Med. 2020, 126, 104046. [Google Scholar]
  8. Hegazy, M.E.F.; Mohamed, T.A.; Alhammady, M.A.; Shaheen, A.M.; Reda, E.H.; Elshamy, A.I.; Aziz, M.; Paré, P.W. Molecular architecture and biomedical leads of terpenes from red sea marine invertebrates. Mar. Drugs 2015, 13, 3154–3181. [Google Scholar]
  9. Hegazy, M.-E.F.; Mohamed, T.A.; Abdel-Latif, F.F.; Alsaid, M.S.; Shahat, A.A.; Pare, P.W. Trochelioid A and B, new cembranoid diterpenes from the Red Sea soft coral Sarcophyton trocheliophorum. Phytochem. Lett. 2013, 6, 383–386. [Google Scholar]
  10. Hegazy, M.-E.F.; Mohamed, T.A.; Elshamy, A.I.; Al-Hammady, M.A.; Ohta, S.; Paré, P.W. Casbane diterpenes from Red Sea coral Sinularia polydactyla. Molecules 2016, 21, 308. [Google Scholar]
  11. Hegazy, M.-E.F.; Mohamed, T.A.; Elshamy, A.I.; Hassanien, A.A.; Abdel-Azim, N.S.; Shreadah, M.A.; Abdelgawad, I.I.; Elkady, E.M.; Paré, P.W. A new steroid from the Red Sea soft coral Lobophytum lobophytum. Nat. Prod. Res. 2016, 30, 340–344. [Google Scholar]
  12. Edwards, A.J.; Head, S.M.; Braithwaite, C.J.R.; Edwards, F.J.; Karbe, L.; Weikert, H.; Thiel, H.; Walker, D.I.; Jones, D.A.; Ghamrawy, M. Key Environments; Red Sea; Pergamon Press: Oxford, UK, 1987. [Google Scholar]
  13. Tseng, Y.-J.; Lee, Y.-S.; Wang, S.-K.; Sheu, J.-H.; Duh, C.-Y. Parathyrsoidins A–D, four new sesquiterpenoids from the soft coral Paralemnalia thyrsoides. Mar. Drugs 2013, 11, 2501–2509. [Google Scholar]
  14. Su, J.-Y.; Zhong, Y.-L.; Zeng, L.-M. Two new sesquiterpenoids from the soft coral Paralemnalia thyrsoides. J. Nat. Prod. 1993, 56, 288–291. [Google Scholar]
  15. Izac, R.R.; Schneider, P.; Swain, M.; Fenical, W. New nor-sesquiterpenoids of apparent nardosinane origin from the pacific soft-coral Paralemnalia thyrsoides. Tetrahedron Lett. 1982, 23, 817–820. [Google Scholar]
  16. Bowden, B.F.; Coll, J.C.; Mitchell, S.J. Studies of Australian soft corals. XIX. Two new sesquiterpenes with the nardosinane skeleton from a Paralemnalia species. Aust. J. Chem. 1980, 33, 885–890. [Google Scholar]
  17. Bishara, A.; Yeffet, D.; Sisso, M.; Shmul, G.; Schleyer, M.; Benayahu, Y.; Rudi, A.; Kashman, Y. Nardosinanols A–I and lemnafricanol, sesquiterpenes from several soft corals, Lemnalia sp., Paralemnalia clavata, Lemnalia africana, and Rhytisma fulvum fulvum. J. Nat. Prod. 2008, 71, 375–380. [Google Scholar]
  18. Huang, H.-C.; Chao, C.-H.; Su, J.-H.; Hsu, C.-H.; Chen, S.-P.; Kuo, Y.-H.; Sheu, J.-H. Neolemnane-type sesquiterpenoids from a Formosan soft coral Paralemnalia thyrsoides. Chem. Pharm. Bull. 2007, 55, 876–880. [Google Scholar]
  19. Huang, H.-C.; Chao, C.-H.; Liao, J.-H.; Chiang, M.Y.; Dai, C.-F.; Wu, Y.-C.; Sheu, J.-H. A novel chlorinated norsesquiterpenoid and two related new metabolites from the soft coral Paralemnalia thyrsoides. Tetrahedron Lett. 2005, 46, 7711–7714. [Google Scholar]
  20. Huang, H.-C.; Wen, Z.-H.; Chao, C.-H.; Ahmed, A.F.; Chiang, M.Y.; Kuo, Y.-H.; Hsu, C.-H.; Sheu, J.-H. Novel sesquiterpenoids from the Formosan soft coral Paralemnalia thyrsoides. Tetrahedron Lett. 2006, 47, 8751–8755. [Google Scholar]
  21. Wang, G.-H.; Huang, H.-C.; Su, J.-H.; Wu, Y.-C.; Sheu, J.-H. Paralemnolins J—P, New Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide. Chem. Pharm. Bull. 2010, 58, 30–33. [Google Scholar]
  22. Huang, C.-Y.; Su, J.-H.; Chen, B.-W.; Wen, Z.-H.; Hsu, C.-H.; Dai, C.-F.; Sheu, J.-H.; Sung, P.-J. Nardosinane-type sesquiterpenoids from the Formosan soft coral Paralemnalia thyrsoides. Mar. Drugs 2011, 9, 1543–1553. [Google Scholar]
  23. Phan, C.-S.; Kamada, T.; Hatai, K.; Vairappan, C.S. Paralemnolins V and W, New Nardosinane-Type Sesquiterpenoids from a Bornean Soft Coral, Lemnalia sp. Chem. Nat. Compd. 2018, 54, 903–906. [Google Scholar]
  24. Wang, S.-K.; Lee, Y.-S.; Duh, C.-Y. Paralemnolide A, an unprecedented bisnorsesquiterpene from the Taiwanese soft coral Paralemnalia thyrsoides. Mar. Drugs 2012, 10, 1528–1535. [Google Scholar]
  25. Lee, Y.-S.; Duh, T.-H.; Siao, S.-S.; Chang, R.-C.; Wang, S.-K.; Duh, C.-Y. New cytotoxic terpenoids from soft corals Nephthea chabroli and Paralemnalia thyrsoides. Mar. Drugs 2017, 15, 392. [Google Scholar]
  26. Wang, Q.; Hu, Z.; Luo, X.; Liu, J.; Li, G.; Cao, S.; Liu, Q. Clavukoellians A–F, highly rearranged nardosinane sesquiterpenoids with antiangiogenic activity from Clavularia koellikeri. J. Nat. Prod. 2019, 82, 1331–1337. [Google Scholar]
  27. Hegazy, M.-E.F.; Mohamed, T.A.; Elshamy, A.I.; Hamed, A.R.; Ibrahim, M.A.A.; Ohta, S.; Umeyama, A.; Paré, P.W.; Efferth, T. Sarcoehrenbergilides D–F: Cytotoxic cembrene diterpenoids from the soft coral Sarcophyton ehrenbergi. RSC Adv. 2019, 9, 27183–27189. [Google Scholar]
  28. Reda, E.H.; Shakour, Z.T.A.; El-Halawany, A.M.; El-Kashoury, E.-S.A.; Shams, K.A.; Mohamed, T.A.; Saleh, I.; Elshamy, A.I.; Atia, M.A.M.; El-Beih, A.A. Comparative Study on the Essential Oils from Five Wild Egyptian Centaurea Species: Effective Extraction Techniques, Antimicrobial Activity and In-Silico Analyses. Antibiotics 2021, 10, 252. [Google Scholar]
  29. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985–990. [Google Scholar]
  30. Shin, K.; Yamauchi, K.; Teraguchi, S.; Hayasawa, H.; Tomita, M.; Otsuka, Y.; Yamazaki, S. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157: H7. Lett. Appl. Microbiol. 1998, 26, 407–411. [Google Scholar]
Figure 1. Structures of isolated compounds (112).
Figure 1. Structures of isolated compounds (112).
Antibiotics 10 01158 g001
Figure 2. Key HMBC and 1H–1H COSY of 1, 2.
Figure 2. Key HMBC and 1H–1H COSY of 1, 2.
Antibiotics 10 01158 g002
Figure 3. Significant NOESY of paralemnolin X, Y (1,2).
Figure 3. Significant NOESY of paralemnolin X, Y (1,2).
Antibiotics 10 01158 g003
Table 1. 1H (CDCl3, 500 MHz) and 13C (125 MHz) NMR of 1 and 2.
Table 1. 1H (CDCl3, 500 MHz) and 13C (125 MHz) NMR of 1 and 2.
No1 2 Paralemnolin F
δHδCδHδCδHδC
1---42.3---38.9---40.9
22.96 s65.32.89 s65.22.62 s71.8
3---55.4---58.3---58.7
45.18 d (3.0)72.54.77 d (6.0)75.55.30 br s73.6
55.13 dd (11.4, 2.4)73.85.09 dd (10.0, 6.0)73.65.27 m71.9
61.82 m, 1.90 m31.31.81 m, 2.10 m31.91.86 m, 1.97 m30.2
72.05 m, 2.41 m30.02.40 m, 2.44 m32.32.15m, 2.42 m29.8
8---143.7---142.1---140.4
95.55 dd (4.3, 2.6)127.15.44 br d (4.5)124.25.58 dd (3.6, 3.8)127.8
102.07 m25.91.96 m, 2.00 m25.82.07 m25.3
111.42 m, 1.46 m25.31.36 m, 1.44 m26.31.50 m25.9
121.80 m39.61.77 m32.31.73 m42.8
130.80 s14.51.20 s21.90.98 s17.0
141.73 s19.51.48 s13.91.48 s20.7
150.98 d (6.9)16.90.94 d (6.9)17.70.97 d (6.9)16.2
CH3-AC2.00 s, 2.08 s21.02.11 s, 2.02 s20.7, 20.92.07s, 2.09 s20.9, 21.1
C=O-Ac---169.9---169.7, 169.9 170.0, 169.9
Table 2. Minimal inhibitory concentration (MIC- µmol) determined by microdilution assay.
Table 2. Minimal inhibitory concentration (MIC- µmol) determined by microdilution assay.
Compound No.Staphylococcus aureusEscherichia coliCandida albicansAspergillus niger
11.488---
21.488---
30.899--1.798
41.562--1.562
50.4491.7981.7982.248
61.893---
7----
80.221--1.773
91.785-1.7850.446
102.110--1.059
111.785--0.446
120.992--0.992
Treflucan--0.3270.163
Thiophenicol 0.1400.281--
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Elshamy, A.I.; Mohamed, T.A.; Elkady, E.M.; Saleh, I.A.; El-Beih, A.A.; Alhammady, M.A.; Ohta, S.; Umeyama, A.; Paré, P.W.; Hegazy, M.-E.F. Paralemnolins X and Y, New Antimicrobial Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide. Antibiotics 2021, 10, 1158. https://doi.org/10.3390/antibiotics10101158

AMA Style

Elshamy AI, Mohamed TA, Elkady EM, Saleh IA, El-Beih AA, Alhammady MA, Ohta S, Umeyama A, Paré PW, Hegazy M-EF. Paralemnolins X and Y, New Antimicrobial Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide. Antibiotics. 2021; 10(10):1158. https://doi.org/10.3390/antibiotics10101158

Chicago/Turabian Style

Elshamy, Abdelsamed I., Tarik A. Mohamed, Eman M. Elkady, Ibrahim A. Saleh, Ahmed A. El-Beih, Montaser A. Alhammady, Shinji Ohta, Akemi Umeyama, Paul W. Paré, and Mohamed-Elamir F. Hegazy. 2021. "Paralemnolins X and Y, New Antimicrobial Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide" Antibiotics 10, no. 10: 1158. https://doi.org/10.3390/antibiotics10101158

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop